MolNFT v1 · #24456 · protein
Bovine thrombin--BM14.1248 complex
1UVT: “Bovine thrombin--BM14.1248 complex”. X-ray diffraction, 1 ligand (I48), 2 pockets (best druggability 0.54). MolNFT v1 #24456 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 1UVT
- Type
- protein
- Length
- 272 residues
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Thrombin
- EC
- 3.4.21.5
- UniProt
- P00735
- Ligands
- I48
- Pockets
- 2 · best druggability 0.54
Structure
x-ray diffraction · 2 distinct chains · 13% helix, 32% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| L | Thrombin (EC 3.4.21.5) | protein | 25 | 32% helix, 0% strand | P00735 |
| H | Thrombin (EC 3.4.21.5) | protein | 247 | 11% helix, 35% strand | P00735 |
Ligands and binding sites
- I48 · N-{3-methyl-5-[2-(pyridin-4-ylamino)-ethoxy]-phenyl}-benzenesulfonamide · ligand · chains H
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 223 | 0.54 | 0.77 | 40 | I48 |
| 2 | 81 | 0.38 | 0.77 | 16 | empty |
Interfaces
1 interface between chains.
- L–H · 1120 Ų buried · 17 hydrogen bonds · protein-protein
Modifications
Observed in the structure: 4 disulfide (disulfide).
Compared structures
- 1UVT · Bovine thrombin--BM14.1248 complex · the same entry in another collection · chain H against H, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P00735
- Elsewhere: RCSB PDB 1UVT · PDBe 1UVT · UniProt P00735
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.